Company Presentation

Cimeio Therapeutics is a Swiss biotech with a pipeline of combined cell & targeted therapy products for, eg, the treatment of aggressive hematological cancers. While our antibody-based therapies such as a CD45-directed ADC fully eradicate leukemia and lymphoma cells a precision-engineered, therapy-resistant stem cell transplant builds up a functional, healthy bone marrow and immune system. This will allow the development of both, curative and tolerable approaches in AML/MDS.